Search Results for 'Hcv Hepatitis'

Hcv Hepatitis published presentations and documents on DocSlides.

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

by jovita

Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...

HCV Assays: Impact on HCV Studies

HCV Assays: Impact on HCV Studies

by blanko

& . Update on HCV . blood bank protocol. . Ov...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...

Update on the HCV Antiviral Pipeline

Update on the HCV Antiviral Pipeline

by natalia-silvester

Todd S. Wills, MD. SPNS HCV Treatment Expansion I...

Treatment with the second-generation HCV protease inhibitor

Treatment with the second-generation HCV protease inhibitor

by conchita-marotz

Results from SILEN-C1 in HCV genotype-1 treatment...

Management of HCV in Co-Infected Patients

Management of HCV in Co-Infected Patients

by danika-pritchard

Marie-Louise Vachon, MD, . MSc. Division of . Inf...

Role of harm reduction in HCV prevention in France: from r

Role of harm reduction in HCV prevention in France: from r

by tatiana-dople

Bruno Spire & Patrizia Carrieri. How to reduc...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

by pamella-moone

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

Sofosbuvir in HCV-

Sofosbuvir in HCV-

by mitsue-stanley

HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...

Access to antiviral drugs for treating HCV for HIV-positive

Access to antiviral drugs for treating HCV for HIV-positive

by yoshiko-marsland

AIDS 2016 | 18-22 July 2016 | Durban, South A...

Housing Choice Voucher Program

Housing Choice Voucher Program

by phoebe-click

LANDLORD BRIEFING. 2015. KHRA & HCV ~ Overvie...

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

by pasty-toler

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

by celsa-spraggs

C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...

An Overview of HIV and HCV in Adolescents and Young Adults

An Overview of HIV and HCV in Adolescents and Young Adults

by pamella-moone

Cathryn. L. Samples, MD, MPH, AAHIVS. Director, ...

O nline census of drug consumption rooms as a setting to address HCV:

O nline census of drug consumption rooms as a setting to address HCV:

by phoebe-click

. current practice and future capacity.. Vendul...

Simplified HCV Therapy in 2018

Simplified HCV Therapy in 2018

by phoebe-click

This program is s. upported. by educational gran...

Care of the Treatment-naive Patient With HCV/HIV Coinfection

Care of the Treatment-naive Patient With HCV/HIV Coinfection

by cheryl-pisano

. Case. 47-Year-Old . Man With Asymptomatic HIV ...

Effects of HIV/HCV coinfection on Bone Mineral Density and Structure

Effects of HIV/HCV coinfection on Bone Mineral Density and Structure

by min-jolicoeur

Amber Wheeler, MD. WIHS Scientific Meeting. June ...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

by giovanna-bartolotta

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

INTEGRATING HIV AND HCV TESTING

INTEGRATING HIV AND HCV TESTING

by cheryl-pisano

30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 2...

Is it possible? HCV Elimination

Is it possible? HCV Elimination

by yoshiko-marsland

Objectives. Define elimination as it relates to i...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

by danika-pritchard

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

OraQuick HCV Rapid Test

OraQuick HCV Rapid Test

by sherrill-nordquist

How to Run the . Test . Overview. Background Pres...

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

by briana-ranney

Sofosbuvir + Ribavirin to Prevent Post-Transplan...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

by robaut

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

Treatment of Chronic HCV

Treatment of Chronic HCV

by lam

with Direct-Acting Antivirals (DAAs). www.hcvguide...

HIV-HCV Coinfection in the era of effective antiviral therapy

HIV-HCV Coinfection in the era of effective antiviral therapy

by mia

Mark Sulkowski, . MD. Professor of Medicine. Medic...

Economic Impact of Eliminating HCV

Economic Impact of Eliminating HCV

by InLoveWithLife

H. . Razavi. April 13, 2016. HCV Economic impact m...

Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro

Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro

by SoulfulDreamer

(Resolution 13). Ad Hoc Disease Transmission Advis...

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA

by WannabeRockstar

seroconversion. and genetically linked HCV infect...

Aptima HCV RNA Qualitative Assay

Aptima HCV RNA Qualitative Assay

by delilah

Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

by desha

mHCV Genotype II Key to symbols used Global Tra...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

by sophia

April 10. –14. , 2019. Vienna, Austria. Disclaim...

Sofosbuvir + Ribavirin in HCV Recurrence

Sofosbuvir + Ribavirin in HCV Recurrence

by williams

Following Liver Transplantation. Phase 2. Charlton...

NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne

NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne

by candy

Supervising Consultant: Dr K. . Rolfe. Update: Mar...

HIV & HCV through the Medicine Wheel

HIV & HCV through the Medicine Wheel

by winnie

Our Services. Emotional:. Reactions. Feelings abou...

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

by ahmir

ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...

HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*

HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*

by jesse588

Mandatory criteria: . Probability based sampling. ...